retatrutide clinical trial results Dr. Tara Narula breaks down new data on the weight-loss drug and the latest results. | Good Morning America Eli Lilly's triple agonist, retatrutide,

The titration schedule is a guideline, not a requirement

Currently, GLP-1 RAs arent recommended for use during pregnancy

The data from semaglutide withdrawal shows that most people regain a significant portion of lost weight within a year of stopping

" More research is needed into why and how these taste change vary across individuals as GLP-1s become an increasingly mainstream option for weight loss, Doty and other experts say especially as use among Americans has more than doubled in the past year

At night you can take some magnesium if you are feeling fatigue

Because your web browser may obtain integrated content directly from third-party servers, the third parties may be able to collect information as if you had visited their sites directly